|
LSM14B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.51630000169811E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.826100E-04 |
| Normal-vs-Stage2 |
1.242210E-01 |
| Normal-vs-Stage3 |
1.177650E-02 |
| Normal-vs-Stage4 |
3.011600E-01 |
| Stage1-vs-Stage2 |
7.147200E-01 |
| Stage1-vs-Stage3 |
3.831600E-01 |
| Stage1-vs-Stage4 |
7.585800E-01 |
| Stage2-vs-Stage3 |
3.186400E-01 |
| Stage2-vs-Stage4 |
9.652400E-01 |
| Stage3-vs-Stage4 |
4.239400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.72099999806719E-08 |
| Normal-vs-AfricanAmerican |
5.910400E-02 |
| Normal-vs-Asian |
2.244100E-02 |
| Caucasian-vs-AfricanAmerican |
2.183800E-02 |
| Caucasian-vs-Asian |
6.706600E-01 |
| AfricanAmerican-vs-Asian |
7.407600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.371800000318E-07 |
| Normal-vs-Female |
2.586300E-04 |
| Male-vs-Female |
7.671600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.411600E-02 |
| Normal-vs-Extreme_Weight |
4.679200E-03 |
| Normal-vs-Obese |
2.009900E-04 |
| Normal-vs-Extreme_Obese |
1.969190E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.544200E-01 |
| Normal_Weight-vs-Obese |
2.271000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.063400E-01 |
| Extreme_Weight-vs-Obese |
2.226000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.476200E-01 |
| Obese-vs-Extreme_Obese |
8.634200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.557700E-04 |
| Normal-vs-Age(41-60Yrs) |
6.40230000015229E-07 |
| Normal-vs-Age(61-80Yrs) |
5.406600E-04 |
| Normal-vs-Age(81-100Yrs) |
5.986600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.620200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.114500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.057900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.918500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.450160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.065400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.21260002039492E-09 |
| Normal-VS-Type2 PRCC |
4.591000E-01 |
| Normal-VS-KIRP CIMP |
2.612600E-01 |
| Normal-VS-Unclassified PRCC |
1.958820E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.577700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.430000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.644800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.228000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.982800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.536600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.313500E-02 |
| Normal-vs-N1 |
3.020100E-03 |
| Normal-vs-N2 |
7.813200E-01 |
| N0-vs-N1 |
1.357230E-01 |
| N0-vs-N2 |
7.228200E-01 |
| N1-vs-N2 |
2.781200E-01 |
|
|
